Inovio Pharmaceuticals
INO
#9800
Rank
A$0.12 B
Marketcap
A$1.48
Share price
6.72%
Change (1 day)
-35.04%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -A$0.14 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.13 Billion, an increase over its 2024 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.14 Billion0.98%
2025 -A$0.13 Billion-15.67%
2024 -A$0.16 Billion-20.03%
2023 -A$0.2 Billion-51.56%
2022 -A$0.4 Billion-8.26%
2021 -A$0.44 Billion95.4%
2020 -A$0.23 Billion36.62%
2019 -A$0.17 Billion20.19%
2018 -A$0.14 Billion10.94%
2017 -A$0.13 Billion9.59%
2016 -A$0.12 Billion118.9%
2015 -A$50.57 Million-10.67%
2014 -A$56.61 Million83.32%
2013 -A$30.88 Million
2011 -A$31.86 Million15.64%
2010 -A$27.55 Million37.7%
2009 -A$20.01 Million2.19%
2008 -A$19.58 Million-14.09%
2007 -A$22.79 Million19.12%
2006 -A$19.13 Million9.62%
2005 -A$17.45 Million5.77%
2004 -A$16.5 Million73.08%
2003 -A$9.54 Million12.75%
2002 -A$8.46 Million
2000 -A$12.8 Million53.93%
1999 -A$8.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.23 B-29,892.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.62 B-18,200.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$15.17 B-12,245.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$15.37 B-12,402.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.84 B-15,182.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.34 B-11,580.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-A$3.95 Million-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-A$0.23 Billion 83.29%๐Ÿ‡บ๐Ÿ‡ธ USA